ImmunologybioRxivPreprint
Anti-GD2 antibody disrupts GD2:Siglec-7 interactions and synergizes with CD47 blockade to mediate tumor eradication
J. Theruvath, M. Menard, B. A. Smith…·R. G. Majzner
This study shows that combining anti-GD2 and anti-CD47 antibodies enhances anti-tumor responses by recruiting macrophages and disrupting the GD2:Siglec-7 interaction in GD2+ cancers.
DOI 10.1101/2021.03.19.436221